For decades, women who could not or would not take hormones had almost nothing that reliably calmed hot flashes and night sweats. That is finally changing. On October 24, 2025, the FDA approved Lynkuet (elinzanetant), Bayer's new non-hormonal drug for moderate-to-severe vasomotor symptoms due to menopause, and it is rolling out to US patients through 2026.
A quick note before we go further: this article is general information, not medical advice. It is meant to help you have a smarter conversation with your own clinician, not to replace one. Prescription decisions about elinzanetant or any menopause treatment should be made with a doctor who knows your history, your liver, your medications, and your goals.
What Lynkuet Actually Is
Lynkuet is the brand name for elinzanetant, a once-daily oral capsule. It treats the classic vasomotor symptoms of menopause: hot flashes and night sweats. It is not a hormone. It does not add estrogen back into your body the way hormone therapy does. Instead, it works on the brain circuit that controls body temperature.
Here is the short version of the biology. Deep in the hypothalamus sit specialized nerve cells nicknamed KNDy neurons, which help run your internal thermostat. As estrogen declines during perimenopause and menopause, these neurons become overactive and start sending faulty "you are overheating" signals. Your body responds with the flush, the sweat, and the sudden heat wave you know too well. Elinzanetant quiets that faulty signaling by blocking neurokinin receptors on these neurons, so the thermostat stops misfiring.
According to Contemporary OB/GYN's coverage of the approval, this brain-targeted approach is why the drug helps even in women who cannot use estrogen.
The First Dual NK1/NK3 Blocker
This is where Lynkuet does something genuinely new. It is the first drug approved that blocks both the NK1 and NK3 receptors.
For context, the other non-hormonal option in this class is Veozah (fezolinetant), approved back in 2023. Veozah blocks only the NK3 receptor. Elinzanetant blocks NK3 plus NK1. NK1 is involved in sleep regulation and mood pathways, which is part of why researchers were interested in whether the dual approach might do more than cool you down.
Neither drug touches estrogen. Both work upstream, on the KNDy neurons and the brain's thermoregulatory center. So if hormone therapy is off the table for you because of personal history, family history, or simple preference, both of these represent a real, non-hormonal path.
If you are building a broader plan for symptom relief, it is worth pairing any prescription with the everyday habits covered in our guide to perimenopause sleep problems and hot flashes, because medication and environment work best together.
What the Trials Showed
The evidence for Lynkuet comes from the Phase 3 OASIS trial program. The results were meaningful:
- At 12 weeks, women taking elinzanetant saw roughly a 74% reduction in moderate-to-severe hot flashes.
- The placebo group saw about a 47% reduction over the same period.
- Beyond hot flash count, participants also reported improved sleep and better menopause-related quality of life.
That sleep and quality-of-life signal is worth pausing on. Hot flashes are miserable in daylight, but the night sweats that soak your sheets at 3 AM may do the most damage, because they wreck the restorative sleep your changing body needs. A drug that reduces the flashes and independently helps sleep is addressing two problems that feed each other.
One honest caveat: the placebo response in these trials was substantial (that 47% figure). Vasomotor symptoms are genuinely responsive to expectation and to time. That does not erase the benefit, but it is a reminder that individual results vary, and your clinician can help set realistic expectations.
While you and your doctor sort out whether a prescription is right, cooling your sleep environment costs nothing to try. A → Shop cooling pillow for menopause on Amazon can take the edge off night heat, and it works whether or not you ever fill a prescription. As an Amazon Associate we earn from qualifying purchases.
Lynkuet vs Veozah: How to Think About the Two
Because these two drugs are close cousins, the natural question is which one matters for you. The honest answer is that this is a conversation for your clinician, but here is the landscape in plain language.
The liver warning is the headline difference. Veozah carries a boxed warning for liver injury. Lynkuet was approved without a boxed liver-injury warning. In the elinzanetant trials, meaningful liver enzyme elevations (transaminases at least three times the upper limit of normal) occurred in about 0.6% of treated women versus about 0.4% on placebo, a much smaller gap than raised concern with the older drug.
That said, "no boxed warning" does not mean "no monitoring." Liver testing is still advised at baseline and again at roughly three months. Do not skip those labs.
The dual receptor mechanism is the other differentiator, with elinzanetant hitting both NK1 and NK3 while fezolinetant hits only NK3.
What they share: both are non-hormonal, both are once-daily oral pills, both target the same brain circuitry rather than estrogen, and both were studied specifically for moderate-to-severe hot flashes and night sweats.
Before your appointment, it helps to have your symptom picture organized. If sleep is your biggest complaint, say so directly; if daytime flashes at work are the problem, say that. The clearer you are, the better your clinician can match a tool to your actual life.
What Lynkuet Does Not Do
This part matters, because it is where a lot of confusion lives. A non-hormonal hot flash drug is a targeted tool, not a replacement for everything estrogen does.
Lynkuet does not treat vaginal or genitourinary symptoms. The dryness, irritation, and discomfort that many women experience come from tissue changes that estrogen affects locally, and a brain-targeted drug simply does not reach that problem. If those symptoms are part of your experience, read our separate guide on perimenopause and vaginal dryness, because they are managed differently.
Lynkuet also does not build bone the way estrogen does. Bone protection is one of the reasons hormone therapy is prescribed for some women, and a hot flash drug is not a substitute for that benefit.
In other words, elinzanetant solves one specific, common, and genuinely distressing problem. It does not solve all of menopause.
Safety, Interactions, and Practical Cautions
A few practical points worth flagging for your clinician conversation:
Liver monitoring. As noted, baseline and roughly three-month liver testing is still advised even without a boxed warning.
Drug interactions. Elinzanetant should be avoided with strong CYP3A4 inhibitors, a category that includes certain antifungals and other common medications. Bring a full, current list of everything you take, prescription and over-the-counter, to your appointment.
Dosing. It is a once-daily oral capsule, but you should confirm the exact dose and timing from the official prescribing information and your pharmacist rather than from any article, including this one.
Rollout timing. Availability is expanding through 2026, so access may vary depending on when and where you are reading this. Bayer's own approval announcement is a useful primary reference for the details.
Where This Fits Alongside Everything Else
New prescription options do not make the basics obsolete. For many women, the smartest plan layers several approaches, and the first layer is the one you control today.
Cool your sleep setup. Breathable, moisture-wicking sleepwear can be the difference between a soaked night and a survivable one. A set of → Shop moisture wicking bamboo pajamas for women on Amazon manages the sweat that ordinary cotton just traps against your skin.
Move air where you sleep. A quiet, targeted airflow source at the bedside gives you fast relief the moment a flash hits at night. A → Shop bedside cooling fan on Amazon is one of the cheapest, most reliable interventions available, and it requires no prescription and no waiting for a rollout.
Support sleep gently. Some women find a magnesium supplement helpful for winding down, though it is not a treatment for hot flashes themselves. If you want to try it, a → Shop magnesium glycinate for sleep on Amazon is a commonly chosen form. Talk to your clinician or pharmacist first if you take other medications or have kidney concerns. For a broader, evidence-minded look at supplements, see our perimenopause supplements starter kit.
Consider hormone therapy if appropriate. For women who are candidates, hormone therapy remains highly effective and does things a hot flash drug cannot, such as protecting bone and treating genitourinary symptoms. Non-hormonal drugs like Lynkuet are not meant to replace hormone therapy for everyone; they exist to serve the many women who cannot or prefer not to use it.
The Bottom Line
Lynkuet (elinzanetant) is a real addition to the menopause toolkit: a once-daily, non-hormonal capsule that meaningfully reduced moderate-to-severe hot flashes in trials, improved sleep and quality of life, and arrived without a boxed liver-injury warning. As the first dual NK1/NK3 blocker, it broadens the non-hormonal options that previously started and ended with Veozah.
It is not magic and it is not for everyone. It will not help vaginal symptoms, it will not build bone, it still requires liver labs, and it interacts with certain common medications. But for a woman drowning in hot flashes and night sweats who cannot take estrogen, having a second well-studied, brain-targeted option is genuine progress.
To repeat the disclaimer, because it matters most on a topic like this: everything above is general information, not medical advice, and drug facts can change as prescribing information is updated. Whether elinzanetant, fezolinetant, hormone therapy, or a lifestyle-first approach is right for you is a decision to make with a clinician who knows your full health picture. Bring your questions, bring your medication list, and bring your real symptoms. That conversation is where the right answer lives.
As an Amazon Associate we earn from qualifying purchases. This article contains affiliate links; if you buy through them we may earn a small commission at no additional cost to you.